Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.

de Greef GE, Braakman E, van der Holt B, Janssen JJWM, Petersen E, Vucinic V, Thuss N, Grootes M, Cornelissen JJ.

Transfusion. 2019 Jan;59(1):316-324. doi: 10.1111/trf.15037. Epub 2018 Dec 11.

PMID:
30548284
2.

Peripheral Stem Cell Apheresis is Feasible Post 131Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution.

Kraal KCJM, Timmerman I, Kansen HM, van den Bos C, Zsiros J, van den Berg H, Somers S, Braakman E, Peek AML, van Noesel MM, van der Schoot CE, Fiocco M, Caron HN, Voermans C, Tytgat GAM.

Clin Cancer Res. 2019 Feb 1;25(3):1012-1021. doi: 10.1158/1078-0432.CCR-18-1904. Epub 2018 Oct 12.

PMID:
30314967
3.

Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation.

Duinhouwer LE, Beije N, van der Holt B, Rijken-Schelen A, Lamers CH, Somers J, Braakman E, Cornelissen JJ.

Bone Marrow Transplant. 2018 Jun;53(6):673-682. doi: 10.1038/s41409-018-0103-y. Epub 2018 Feb 9.

PMID:
29426829
4.

Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human.

Aerts JGJV, de Goeje PL, Cornelissen R, Kaijen-Lambers MEH, Bezemer K, van der Leest CH, Mahaweni NM, Kunert A, Eskens FALM, Waasdorp C, Braakman E, van der Holt B, Vulto AG, Hendriks RW, Hegmans JPJJ, Hoogsteden HC.

Clin Cancer Res. 2018 Feb 15;24(4):766-776. doi: 10.1158/1078-0432.CCR-17-2522. Epub 2017 Dec 12.

5.

Multicenter study to evaluate a new enumeration method for hematopoietic stem cell collection management.

Grommé M, Russcher H, Braakman E, Klinkspoor JH, Dobber JA, de Greef I, de Wit NCJ.

Transfusion. 2017 Aug;57(8):1949-1955. doi: 10.1111/trf.14183. Epub 2017 Jun 26.

PMID:
28653370
6.

Lipid-mediated Wnt protein stabilization enables serum-free culture of human organ stem cells.

Tüysüz N, van Bloois L, van den Brink S, Begthel H, Verstegen MM, Cruz LJ, Hui L, van der Laan LJ, de Jonge J, Vries R, Braakman E, Mastrobattista E, Cornelissen JJ, Clevers H, Ten Berge D.

Nat Commun. 2017 Mar 6;8:14578. doi: 10.1038/ncomms14578.

7.

CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation.

Lamers CH, Wijers R, van Bergen CA, Somers JA, Braakman E, Gratama JW, Debets R, Falkenburg JH, Cornelissen JJ.

Blood. 2016 Oct 27;128(17):2165-2174. Epub 2016 Aug 16.

8.

Osteoblasts secrete miRNA-containing extracellular vesicles that enhance expansion of human umbilical cord blood cells.

Morhayim J, van de Peppel J, Braakman E, Rombouts EW, Ter Borg MN, Dudakovic A, Chiba H, van der Eerden BC, Raaijmakers MH, van Wijnen AJ, Cornelissen JJ, van Leeuwen JP.

Sci Rep. 2016 Sep 2;6:32034. doi: 10.1038/srep32034.

9.

Magnetic Resonance Detection of CD34+ Cells from Umbilical Cord Blood Using a 19F Label.

Duinhouwer LE, van Rossum BJ, van Tiel ST, van der Werf RM, Doeswijk GN, Haeck JC, Rombouts EW, Ter Borg MN, Kotek G, Braakman E, Cornelissen JJ, Bernsen MR.

PLoS One. 2015 Sep 22;10(9):e0138572. doi: 10.1371/journal.pone.0138572. eCollection 2015.

10.

Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures.

Duinhouwer LE, Tüysüz N, Rombouts EW, Ter Borg MN, Mastrobattista E, Spanholtz J, Cornelissen JJ, Ten Berge D, Braakman E.

PLoS One. 2015 Mar 25;10(3):e0119086. doi: 10.1371/journal.pone.0119086. eCollection 2015.

11.

Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.

Somers JA, Braakman E, van der Holt B, Petersen EJ, Marijt EW, Huisman C, Sintnicolaas K, Oudshoorn M, Groenendijk-Sijnke ME, Brand A, Cornelissen JJ.

Haematologica. 2014 Nov;99(11):1753-61. doi: 10.3324/haematol.2014.106690. Epub 2014 Aug 8.

12.

Double umbilical cord blood transplantation: a study of early engraftment kinetics in leukocyte subsets using HLA-specific monoclonal antibodies.

Somers JA, Brand A, van Hensbergen Y, Mulder A, Oudshoorn M, Sintnicolaas K, Gratama JW, Falkenburg JH, Braakman E, Cornelissen JJ.

Biol Blood Marrow Transplant. 2013 Feb;19(2):266-73. doi: 10.1016/j.bbmt.2012.09.022. Epub 2012 Oct 3.

13.

Peripheral stem cell harvest using regular chemotherapy schedules in childhood cancer.

Gooskens SL, Braakman E, van den Boom AL, So-Osman C, de Winter F, Pieters R, van den Heuvel-Eibrink MM.

Pediatr Transplant. 2012 Nov;16(7):758-65. doi: 10.1111/j.1399-3046.2012.01754.x. Epub 2012 Aug 9.

PMID:
22882589
14.

Keratinocyte growth factor and stem cell factor to improve thymopoiesis after autologous CD34+ cell transplantation in rhesus macaques.

Wils EJ, Aerts-Kaya FS, Rombouts EJ, van Mourik I, Rijken-Schelen A, Visser TP, Braakman E, Wagemaker G, Cornelissen JJ.

Biol Blood Marrow Transplant. 2012 Jan;18(1):55-65. doi: 10.1016/j.bbmt.2011.09.010. Epub 2011 Oct 1.

15.

Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow).

Rosskopf K, Ragg SJ, Worel N, Grommé M, Preijers FW, Braakman E, Schuurhuis GJ, van Riet I, Wendel S, Fontão-Wendel R, Lazar A, Goldman M, Halpenny M, Giulivi A, Letcher B, McGann L, Korhonen M, Arvola A, Humpe A, Buwitt-Beckmann U, Wiesneth M, Schauwecker P, Schrezenmeier H, Bönig H, Henschler R, Seifried E, Accorsi P, Bonfini T, Takanashi M, van Beckhoven JM, Brand A, Gounder D, Wong A, Dooccey R, Forrest E, Galea G, Smythe J, Pawson R, Reems JA, Oh J, Reesink HW, Panzer S.

Vox Sang. 2011 Oct;101(3):255-75. doi: 10.1111/j.1423-0410.2011.01471.x. No abstract available.

PMID:
21923889
16.

Stem cell factor consistently improves thymopoiesis after experimental transplantation of murine or human hematopoietic stem cells in immunodeficient mice.

Wils EJ, Rombouts EJ, van Mourik I, Spits H, Legrand N, Braakman E, Cornelissen JJ.

J Immunol. 2011 Sep 15;187(6):2974-81. doi: 10.4049/jimmunol.1004209. Epub 2011 Aug 22.

17.

Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients.

Wils EJ, van der Holt B, Broers AE, Posthumus-van Sluijs SJ, Gratama JW, Braakman E, Cornelissen JJ.

Haematologica. 2011 Dec;96(12):1846-54. doi: 10.3324/haematol.2011.047696. Epub 2011 Aug 22.

18.

The impact of CD4+Foxp3+ Treg on immunity to murine cytomegalovirus after bone marrow transplantation depends on the peripheral or thymic source of T cell regeneration.

Bruinsma M, Wils EJ, Löwenberg B, Cornelissen JJ, Braakman E.

Transpl Immunol. 2010 Oct;24(1):9-16. doi: 10.1016/j.trim.2010.08.003. Epub 2010 Aug 27.

PMID:
20801217
19.

Keratinocyte growth factor improves allogeneic bone marrow engraftment through a CD4+Foxp3+ regulatory T cell-dependent mechanism.

Bruinsma M, van Soest PL, Leenen PJ, Löwenberg B, Cornelissen JJ, Braakman E.

J Immunol. 2009 Jun 15;182(12):7364-9. doi: 10.4049/jimmunol.0803253.

20.

Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products.

Braakman E, Schuurhuis GJ, Preijers FW, Voermans C, Theunissen K, van Riet I, Fibbe WE, Slaper-Cortenbach I.

Cytotherapy. 2008;10(1):83-9. doi: 10.1080/14653240701787650.

PMID:
18202977
21.

Keratinocyte growth factor induces expansion of murine peripheral CD4+Foxp3+ regulatory T cells and increases their thymic output.

Bruinsma M, van Soest PL, Leenen PJ, Lambrecht BN, Cupedo T, Löwenberg B, Cornelissen JJ, Braakman E.

J Immunol. 2007 Dec 1;179(11):7424-30.

22.

IL-7-mediated protection against minor-antigen-mismatched allograft rejection is associated with enhanced recovery of regulatory T cells.

Broers AE, Bruinsma M, Posthumus-van Sluijs SJ, Wils EJ, Spits H, Löwenberg B, Braakman E, Cornelissen JJ.

Haematologica. 2007 Aug;92(8):1099-106.

23.

Flt3 ligand expands lymphoid progenitors prior to recovery of thymopoiesis and accelerates T cell reconstitution after bone marrow transplantation.

Wils EJ, Braakman E, Verjans GM, Rombouts EJ, Broers AE, Niesters HG, Wagemaker G, Staal FJ, Löwenberg B, Spits H, Cornelissen JJ.

J Immunol. 2007 Mar 15;178(6):3551-7.

24.

Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome.

Smalberg JH, Darwish Murad S, Braakman E, Valk PJ, Janssen HL, Leebeek FW.

Haematologica. 2006 Dec;91(12):1712-3.

25.
26.

A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.

Cornelissen JJ, van der Holt B, Petersen EJ, Vindelov L, Russel CA, Höglund M, Maertens J, Schouten HC, Braakman E, Steijaert MM, Zijlmans MJ, Slaper-Cortenbach I, Boogaerts MA, Löwenberg B, Verdonck LF.

Exp Hematol. 2003 Oct;31(10):855-64.

PMID:
14550800
27.

Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells.

Commeren DL, Van Soest PL, Karimi K, Löwenberg B, Cornelissen JJ, Braakman E.

Immunology. 2003 Oct;110(2):188-96.

28.

Human primary T lymphocytes have a low capacity to amplify MLV-based amphotropic RCR and the virions produced are largely noninfectious.

Ebeling SB, Simonetti ER, Borst HP, Blok A, Schelen AM, Braakman E, Ederveen J, Hagenbeek A.

Gene Ther. 2003 Oct;10(21):1800-6.

PMID:
12960969
29.

Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants.

Broers AE, Posthumus-van Sluijs SJ, Spits H, van der Holt B, Löwenberg B, Braakman E, Cornelissen JJ.

Blood. 2003 Aug 15;102(4):1534-40. Epub 2003 Apr 24.

30.

Biodistribution and retention time of retrovirally labeled T lymphocytes in mice is strongly influenced by the culture period before infusion.

Kolen S, Dolstra H, van de Locht L, Braakman E, Schattenberg A, de Witte T, van de Wiel-van Kemenade E.

J Immunother. 2002 Sep-Oct;25(5):385-95.

PMID:
12218776
31.

Quantification of newly developed T cells in mice by real-time quantitative PCR of T-cell receptor rearrangement excision circles.

Broers AE, Meijerink JP, van Dongen JJ, Posthumus SJ, Löwenberg B, Braakman E, Cornelissen JJ.

Exp Hematol. 2002 Jul;30(7):745-50.

PMID:
12135672
32.
33.

Comparison of single and dual-platform assay formats for CD34+ haematopoietic progenitor cell enumeration.

Gratama JW, Braakman E, Kraan J, Lankheet P, Levering WH, Van Den Beemd MW, Van Der Schoot CE, Wijermans P, Preijers F.

Clin Lab Haematol. 1999 Oct;21(5):337-46.

PMID:
10646076
34.

Ganciclovir-mediated in vivo elimination of myeloid leukemic cells expressing the HSVtk gene induces HSVtk loss variants.

Braakman E, Vogels R, Martens AC, Vermeulen J, Bron M, Hoogerbrugge PM, Valerio D, Hagenbeek A.

Gene Ther. 1999 Jun;6(6):1139-46.

35.

Second gene expression in bicistronic constructs using short synthetic intercistrons and viral IRES sequences.

Havenga MJ, Vogels R, Braakman E, Kroos N, Valerio D, Hagenbeek A, van Es HH.

Gene. 1998 Nov 19;222(2):319-27.

PMID:
9831667
36.

Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.

Gowing H, Braakman E, Hagenbeek A, Lawler M, McCann SR, Pamphilon DH, Martens AC.

Bone Marrow Transplant. 1998 Apr;21(8):801-7.

37.

Effect of ultraviolet-B light on lymphocyte activity at doses at which normal bone marrow stem cells are preserved.

Gowing H, Lawler M, Hagenbeek A, McCann SR, Pamphilon DH, Hudson J, van Weelden H, Braakman E, Martens AC.

Blood. 1996 Feb 15;87(4):1635-43.

38.

Clustered CD3/TCR complexes do not transduce activation signals after bispecific monoclonal antibody-triggered lysis by cytotoxic T lymphocytes via CD3.

Blank-Voorthuis CJ, Braakman E, Ronteltap CP, Tilly BC, Sturm E, Warnaar SO, Bolhuis RL.

J Immunol. 1993 Sep 15;151(6):2904-14.

PMID:
8376761
39.

Retrovirus-mediated gene transfer into rhesus monkey hematopoietic stem cells: the effect of viral titers on transduction efficiency.

Van Beusechem VW, Bakx TA, Kaptein LC, Bart-Baumeister JA, Kukler A, Braakman E, Valerio D.

Hum Gene Ther. 1993 Jun;4(3):239-47.

PMID:
8338872
40.

Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2.

Gratama JW, Bruin RJ, Lamers CH, Oosterom R, Braakman E, Stoter G, Bolhuis RL.

Clin Exp Immunol. 1993 May;92(2):185-93.

41.

Bone marrow gene therapy for adenosine deaminase deficiency.

Kaptein LC, Einerhand MP, Braakman E, Valerio D, van Beusechem VW.

Immunodeficiency. 1993;4(1-4):335-45. Review.

PMID:
7909479
42.

Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cells.

De Lau WB, Boom SE, Heije K, Griffioen AW, Braakman E, Bolhuis RL, Tax WJ, Clevers H, Bast BJ.

J Immunol. 1992 Sep 15;149(6):1840-6.

PMID:
1387662
43.

CD16 on human gamma delta T lymphocytes: expression, function, and specificity for mouse IgG isotypes.

Braakman E, van de Winkel JG, van Krimpen BA, Jansze M, Bolhuis RL.

Cell Immunol. 1992 Aug;143(1):97-107.

PMID:
1377991
44.

Optimization of culture conditions for activation and large-scale expansion of human T lymphocytes for bispecific antibody-directed cellular immunotherapy.

Lamers CH, van de Griend RJ, Braakman E, Ronteltap CP, Bénard J, Stoter G, Gratama JW, Bolhuis RL.

Int J Cancer. 1992 Jul 30;51(6):973-9.

PMID:
1386349
45.

Genetic correction of cultured T cells from an adenosine deaminase-deficient patient: characteristics of non-transduced and transduced T cells.

Braakman E, Van Beusechem VW, Van Krimpen BA, Fischer A, Bolhuis RL, Valerio D.

Eur J Immunol. 1992 Jan;22(1):63-9.

PMID:
1730260
46.

Engineering T lymphocyte antigen specificity.

Bolhuis RL, Sturm E, Gratama JW, Braakman E.

J Cell Biochem. 1991 Dec;47(4):306-10. Review.

PMID:
1724446
47.

Expression of CD45 isoforms by fresh and activated human gamma delta T lymphocytes and natural killer cells.

Braakman E, Sturm E, Vijverberg K, van Krimpen BA, Gratama JW, Bolhuis RL.

Int Immunol. 1991 Jul;3(7):691-7.

PMID:
1832950
48.

Daudi cell specificity correlates with the use of a V gamma 9-V delta 2 encoded TCR gamma delta.

Sturm E, Braakman E, Fisch P, Sondel PM, Bolhuis RL.

Curr Top Microbiol Immunol. 1991;173:183-8. Review. No abstract available.

PMID:
1833141
49.

Function and specificity of human V gamma 9/V delta 2 T lymphocytes.

Fisch P, Kovats S, Fundim N, Sturm E, Braakman E, DeMars R, Bolhuis RL, Sondel PM, Malkovsky M.

Curr Top Microbiol Immunol. 1991;173:179-82. Review. No abstract available.

PMID:
1833140
50.

T cell targeting in cancer therapy.

Bolhuis RL, Sturm E, Braakman E.

Cancer Immunol Immunother. 1991;34(1):1-8. Review.

PMID:
1760806

Supplemental Content

Loading ...
Support Center